Pict.: Surfaces in hospital rooms such as tray tables, bedrails, call buttons and grab bars can be reservoirs for bacteria. A new UV light method for cleaning hospital rooms could help stop the spread of dangerous bacteria, and in turn, save lives. Texas A&M Health Science CenterUV light robot to clean hospital rooms could help stop spread of ’superbugs‘

 

BRYAN, Texas, USA (April 14, 2015) – Can a robot clean a hospital room just as well as a person? According to new research out of the Texas A&M Health Science Center College of Medicine, that is indeed the case. Chetan Jinadatha, M.D., M.P.H., assistant professor at the Texas A&M College of Medicine and chief of infectious diseases at the Central Texas Veterans Health Care System in Temple, is studying the effectiveness of a germ-zapping robot to clean hospital rooms, which could hold the key to preventing the spread of "superbugs" – in turn, saving countless dollars and, most importantly, lives. 


Keeping hospital rooms clean is important to prevent the spread of infections from one patient to another. Surfaces in hospital rooms such as tray tables, bedrails, call buttons and grab bars can be reservoirs for bacteria such as methicillin-resistant Staphylococcus aureus (MRSA), which can be difficult to treat, and in some cases, fatal.

 

"A typical 100-bed hospital sees about 10-20 hospital-acquired infections a year," Jinadatha says. "Our goal is to get to zero infections."

 

In addition to the human toll, hospitals now have a financial reason to reduce hospital-acquired infections: beginning in 2017, the federal government will dramatically reduce Medicare payments to hospitals that exceed incidences of certain conditions, such as hospital-acquired infections.

 

Since the current method of cleaning hospital rooms relies heavily on housekeeping staff, who often have a high turnover rate, Jinadatha has focused his research on using technology to prevent hospital-acquired infections. In particular, he is studying the effectiveness of a pulsed xenon ultraviolet (UV) light system that was developed in Texas. Jinadatha has been among the first to study the system since it was introduced in 2011.

 

The device – which Jinadatha admits bears a striking resemblance to the fictional robot in Star Wars known as R2-D2 – has a large saucer-shaped head on top of a column that rises up to reveal a bulb filled with xenon gas. When the system is switched on, high-voltage electricity passes through the bulb and releases a spectrum of UV light that binds to the DNA of organisms and kills them.

 

Last year, Jinadatha published a study that compared the effectiveness of manual disinfection alone to manual disinfection plus the use of UV light. This study found that manual cleaning plus UV light killed more than 90 percent of the bacteria, compared to 70 percent with manual cleaning alone. Of particular note was the fact that manual disinfection plus UV light killed 99 percent of the bacteria that cause MRSA.

 

Jinadatha’s latest study, which was published earlier this year in the American Journal of Infection Control, looked at the effectiveness of UV light disinfection by itself. This study found that in just 12 minutes, the UV light system cut the amount bacteria in the room by about 70 percent – roughly the same level of effectiveness as manual disinfection.

 

Jinadatha stresses that he would never recommend that a hospital use the UV light system by itself, but he believes it does have value as a "safety net" to kill bacteria that traditional cleaning may miss. Currently the system is being used in 40 VA hospitals across the country and about 200 private hospitals. He predicts it will eventually become standard equipment at all hospitals.

 

"There is no one thing that will take away the problem of hospital-acquired infections, but we are slowly chipping away at it," he says.

 

 

Pict.: Surfaces in hospital rooms such as tray tables, bedrails, call buttons and grab bars can be reservoirs for bacteria. A new UV light method for cleaning hospital rooms could help stop the spread of dangerous bacteria, and in turn, save lives. Texas A&M Health Science Center

 


Texas A&M University, 14.04.2015 (tB).

MEDICAL NEWS

New guidance to prevent the tragedy of unrecognized esophageal intubation
Overly restrictive salt intake may worsen outcomes for common form…
COVID-19 vaccines are estimated to have prevanented 20 million deaths…
Novel sleep education learning modules developed for nurse practitioners
Scientists discover how salt in tumours could help diagnose and…

SCHMERZ PAINCARE

Aktuelle Versorgungssituation der Opioidtherapie im Fokus
Individuelle Schmerztherapie mit Opioiden: Patienten im Mittelpunkt
Versorgung verbessern: Deutsche Gesellschaft für Schmerzmedizin fordert die Einführung des…
Pflegeexpertise im Fokus: Schmerzmanagement nach Operationen
Versorgung verbessern: Bundesweite Initiative der Deutschen Gesellschaft für Schmerzmedizin zu…

DIABETES

Kaltplasma bei diabetischem Fußsyndrom wirkt via Wachstumsfaktoren
Typ-1-Diabetes: InRange – auf die Zeit im Zielbereich kommt es…
Suliqua®: In komplexem Umfeld – einfach besser eingestellt
Suliqua®: Überlegene HbA1c-Senkung  im Vergleich zu Mischinsulinanalogon
„Wissen was bei Diabetes zählt: Gesünder unter 7 PLUS“ gibt…

ERNÄHRUNG

Gesunde Ernährung: „Nicht das Salz und nicht das Fett verteufeln“
Mangelernährung gefährdet den Behandlungserfolg — DGEM: Ernährungsscreening sollte zur klinischen…
Wie eine Diät die Darmflora beeinflusst: Krankenhauskeim spielt wichtige Rolle…
DGEM plädiert für Screening und frühzeitige Aufbautherapie: Stationäre COVID-19-Patienten oft…
Führt eine vegane Ernährungsweise zu einer geringeren Knochengesundheit?

ONKOLOGIE

Krebspatienten unter Immuntherapie: Kein Hinweis auf erhöhtes Risiko für schwere…
Aktuelle Kongressdaten zum metastasierten Mammakarzinom und kolorektalen Karzinom sowie Neues…
Mehr Lebensqualität für onkologische Patient:innen durch bessere Versorgung: Supportivtherapie, Präzisionsonkologie,…
WHO veröffentlicht erste Klassifikation von Tumoren im Kindesalter
Anti-Myelom-Therapie mit zusätzlich Daratumumab noch effektiver

MULTIPLE SKLEROSE

Multiple Sklerose: Analysen aus Münster erhärten Verdacht gegen das Epstein-Barr-Virus
Aktuelle Daten zu Novartis Ofatumumab und Siponimod bestätigen Vorteil des…
Multiple Sklerose durch das Epstein-Barr-Virus – kommt die MS-Impfung?
Neuer Therapieansatz für Multiple Sklerose und Alzheimer
„Ich messe meine Multiple Sklerose selbst!“ – Digitales Selbstmonitoring der…

PARKINSON

Alexa, bekomme ich Parkinson?
Meilenstein in der Parkinson-Frühdiagnose
Parkinson-Erkrankte besonders stark von Covid-19 betroffen
Gangstörungen durch Kleinhirnschädigung beim atypischen Parkinson-Syndrom
Parkinson-Agenda 2030: Die kommenden 10 Jahre sind für die therapeutische…